CABA Cabaletta Bio Inc

$CABA Bain, Lily and co invested $150,000,000 at $2.90 only 23 weeks ago. ALL executive Insiders bought substantially at market at $2.26 odd beginning of this year. Only good news and more cash in the bank from fully advertised warrant sales = approx $350,000,000 in the bank. $LLY chief science officer advising the board. Potential cure for multiple autoimmune diseases and possibly preconditioning free. Multi billion potential. Trading below cash in the bank value. Zero enterprise or technology value? Mark this post…👍

$CABA I wish we can sign a petition to limit the shorts action especially in small/ micro cap . It should not be allowed in specific sizes.

$CABA this is what iam talking about. short sellers are buing back. this thing happen every single f day

$CABA added my last available 20k at the possible triple bottom 1.54. I was going to wait until tomorrow but it's done. Much appreciate tbe adjusted DCA! Now let's go Green tomorrow

$CABA I am not worried about this one. As we can see whole stock market is going down recently. Patience is the key to success.

$CABA now announce a presentation for November and at that time reveal more solid Preconditioning free efficacy data. Back to $4. My personal prediction.

$CABA I cannot begin to imagine two stocks with more Explosive potential than Cabaletta Bio and $ALT Altimmune... $SPY

$CABA Entered a starter here. Should be a 2027 big Winner. Never to early to start collecting shares.

$CABA a lot of pharmaceutical companies are down 50-60% aint only cabaletta. Now its not time to sell.. if you are losing 30-60% and you are selling because of the panic attack i dont know what to say probably you are not for this kind of market and stocks. . This price is for buying and the big funds are knowing that. If they decide to buy then the price will explode. If you have patient until the mid of november the price will be a lot different then. .

Why is $CABA about to run? There’s a huge divergence on 20 and 200 EMAs. RSI super low. Technicals are such that algos are picking this up and the run starts this week, even today. That yellow and blue line are absolutely too far away from eachother and they just can’t stretch any further. Warrants were priced at $2.50 so this is also very undervalued now. Amazing product too. Lots of reasons to reverse NOW! $PDSB $IBRX

$CABA weak jobs report today Looks like that will put a stop to any future rate hikes That the Dems were hoping for lol The Fed has two mandates Full employment Price stability Will be talking about cutting rates next Specially, with an Iran deal All up from here for Small Caps I think we’ll finish strong today Doesn’t really matter to me this is a long hold When you lease expect it 💥   

$CABA options activity still skews BULLISH - maybe some movement before next Friday! Big money was bet. Someone spent about one hundred fifty thousand dollars on October sixteenth four-dollar calls on September second, when the stock was near three fifty. That’s a bet that CABA would more than double in six weeks — a binary bet on a clinical or partnership catalyst that never came. The position is still open, which means the buyer hasn’t cut it. That’s either conviction or an inability to exit. The implied volatility on that contract is running near five hundred percent, so the market is pricing in a real chance of a violent move before Friday. The rest of the chain is heavily call-heavy — twenty-nine thousand contracts of call open interest versus eight thousand puts — with the January fifteenth five-dollar and three-dollar calls carrying the next largest positions. So the positioning is still bullish, even after the September calls expired worthless. The bull case is that the January calls represent fresh money, not leftovers, and that a catalyst hits before January fifteenth

$CABA We have passed the stage of high downward volume and are now in the stage where the stock remains stable with low volume. The next stage is for the price to rise with high volume. Just a little more patience. Naturally, this is a great opportunity for those who haven't entered CABA yet or have entered with a small capital.

$CABA warrants absorbed, interest rate hikes absorbed, hammer on the daily/weekly, bottom already hit, trading below institutional positions at cash valuation with no regards to the science and advancement this company has made, this reeks of a violent recovery + new 52 week highs coming off minor news, short positions have been thined out for a reason 🚀

$CABA $KYTX CABA data for DM and SLE is pretty good. But for gMG, KYTX has the best data Among all competitors.

$CABA It’s a tough fight and I am planning to fight against the shorts. Technically it needs to get a strong support around 1.50 levels but this is s good example why it’s too important to have plans and nevee go all in one in any stock no matter what!

$CABA guys the entire market is down 50%, the only ones who did not drop much are the ones who were already hammered down. Macro shit going on, this is a risk off environment. See you in 2027

$CABA Guys and girls, hold on a little longer, I've been here for over 2 years. Institutions like these low prices so that they can accumulate. These large transactions are mostly played on Darkpool, and then they just register on Nasdaq. Greetings and hold on a little longer, I hope

$CABA I love days like today. This is when wealth is made Bought another 51,400 shares at 2:22 bringing my average down to $2.57. Now 151,400 shares. Folks, this is temporary. This is the dip before the eventual rip. These are my favorite kind of days. Let’s go!

$CABA Cabaletta Bio reported approximately $128.2 million in gross proceeds from the exercise of about 51.3 million warrants. That includes roughly $115 million raised after June 30. The company’s previously reported cash runway into mid-2027 was based on its June 30 cash balance, before those later warrant proceeds. That’s a significant amount of additional capital, and I’m looking forward to an updated picture of CABA’s cash position and expected runway. I still believe in the company’s potential. Now I’d like to see management share how this funding strengthens the road ahead.